Data Presented At Two Global Medical Congresses Reinforce Significant Benefit Of Enbrel(R) For Patients With Chronic Inflammatory Conditions

Podiatry Arena Data Presented At Two Global Medical Congresses Reinforce Significant Benefit Of Enbrel(R) For Patients With Chronic Inflammatory Conditions

Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

If you have any problems with the registration process or your account login, please contact contact us.

Data Presented At Two Global Medical Congresses Reinforce Significant Benefit Of Enbrel(R) For Patients With Chronic Inflammatory Conditions

Submit Thread >

< Submit Thread

Thread Tools

Display Modes

25th May 2011, 05:20 PM

RSSFeedBot RSSFeedBot is offline

I, Robot

About:

Join Date: Jul 2008

Posts: 10,130

Join Date: Jul 2008

Marketplace reputation 0% (0)

CPD Points: 1

Thanks: 0

Thanked 22 Times in 22 Posts

Data Presented At Two Global Medical Congresses Reinforce Significant Benefit Of Enbrel(R) For Patients With Chronic Inflammatory Conditions

Podiatry Arena members do not see these ads

Pfizer (NYSE: PFE) today announced new results from multiple studies of ENBREL (etanercept), further expanding the body of evidence supporting the efficacy and safety profile of ENBREL, the most prescribed biologic by rheumatologists worldwide...

More...

Sponsored Links

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts	vB code is On Smilies are On [IMG] code is On HTML code is On

Forum Jump

Translate This Page

Similar Threads

Thread	Thread Starter	Forum	Replies	Last Post
More Patients Research Their Own Diseases, Seek To Manage Chronic Conditions	RSSFeedBot	Latest Diabetes Medicine Research & News	0	2nd September 2010 07:40 AM
Pro-Pointer, Inc. Introduces New Supplement For Arthritic And Inflammatory Conditions	RSSFeedBot	Latest Rheumatology News	0	7th June 2010 06:10 AM
Ossulin? Oral Insulin Data To Be Presented At The San Francisco Diabetes Congress On November 6, 2009	RSSFeedBot	Latest Diabetes Medicine Research & News	0	6th November 2009 06:20 PM
Two-Year Data Reinforce Effect Of ACTEMRA(R) (tocilizumab) In Inhibiting Progression Of Joint Damage And Improving Physical Function In Arthritis	RSSFeedBot	Latest Rheumatology News	0	26th May 2009 04:20 AM
New Survey Uncovers Significant Food Economising Amongst Type 2 Diabetes Population. Is Global Credit Crunch To Blame?	RSSFeedBot	Latest Diabetes Medicine Research & News	0	3rd February 2009 10:10 AM

New To Site?	Need Help?
Register to Participate View Forum Leaders Contact Us	Frequently Asked Questions Did you forget your password? Mark Forums Read

Finding your way around:

Browse the forums.

Search the site.

Browse the tags.

Search the tags.

All times are GMT -7. The time now is 06:10 AM.

User Name		Remember Me?
Password